US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Valion Bio Inc

2.51

-0.2900-10.36%

Post-market: 2.46-0.0500-1.99%19:50 EDT

Volume:680.17K

Turnover:1.77M

Market Cap:2.23M

PE:-0.01

High:2.75

Open:2.55

Low:2.48

Close:2.80

52wk High:78.75

52wk Low:2.05

Shares:887.60K

Float Shares:887.60K

Volume Ratio:0.05

T/O Rate:76.63%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-210.1984

EPS(LYR):-192.0762

ROE:-459.52%

ROA:-57.13%

PB:0.52

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Valion Bio, Shear Kershman formulate oral mucosal entolimod

Valion Bio, Shear Kershman Complete Oral Mucosal Entolimod Formulation Milestone

Valion Bio appoints Dean Zikria as interim CEO, Thomas Jensen as chair

Valion Bio - Appoints Dean Zikria as Interim CEO Effective September 22, 2026 - SEC Filing

THOMSON REUTERS

Valion Bio Names Dean Zikria Interim CEO

Valion Bio regains compliance with Nasdaq minimum bid price listing rule

Valion Bio Regains NASDAQ Compliance with $1 Minimum Bid Price Rule

Valion Bio Files Initial Beneficial Ownership Statement for Director Thomas Jensen

Valion Bio Inc: Lisa Wolf Appointed as President & Chief Operating Officer; to Continue to Serve as CFO

THOMSON REUTERS

Valion Bio Names CFO Lisa Wolf President, COO After CEO Handley Exits

Valion Bio Inc trading halted, news pending

Valion Bio - 1-for-25 Reverse Stock Split, Become Effective on August 31 - SEC Filing

THOMSON REUTERS

Valion Bio Announces 1-for-25 Reverse Stock Split Effective Aug. 31

Valion Bio Amends 8-K to Report Final Vote Tally on Reverse Stock Split Approval

Valion Bio Agrees to Sell 1,500 Series B Preferred Shares to 3i for $1.5 Million in Private Placement

Valion Bio - Michael K. Handley Terminated as Chief Executive Officer, Effective August 16 - SEC Filing

THOMSON REUTERS

Valion Bio Q2 Net Loss Widens to $7.1 Million; Operating Loss Deepens to $6.4 Million

Ukraine Health Ministry Starts Technical Assessment of Valion Bio’s Entolimod Dossier

Top Premarket Decliners

MT Newswires Live

Valion Bio Says U.S.-Funded Entolimod Safety Study for Radiation-Induced GI Injury Starts This Week

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/VBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","market":"US","secType":"STK","nameCN":"Valion Bio Inc","latestPrice":2.51,"timestamp":1790884800000,"preClose":2.8,"halted":0,"volume":680173,"hourTrading":{"tag":"盘后","latestPrice":2.46,"preClose":2.51,"latestTime":"19:50 EDT","volume":12471,"amount":31100.910600599997,"timestamp":1790898633552,"change":-0.05,"changeRate":-0.01992,"amplitude":0.055777},"delay":0,"changeRate":-0.10357142857142859,"floatShares":887600,"shares":887600,"eps":-210.1984,"marketStatus":"Post-Mkt","change":-0.29,"latestTime":"10-01 19:53:09 EDT","open":2.55,"high":2.75,"low":2.48,"amount":1770592.4129673,"amplitude":0.096429,"askPrice":2.54,"askSize":9,"bidPrice":2.44,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-210.1984,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"listingDate":1636606800000,"exchange":"NASDAQ","adjPreClose":2.8,"preHourTrading":{"tag":"盘前","latestPrice":2.7,"preClose":2.8,"latestTime":"09:29 EDT","volume":54666,"amount":147745.360872,"timestamp":1790861341416,"change":-0.1,"changeRate":-0.035714,"amplitude":0.107143},"postHourTrading":{"tag":"盘后","latestPrice":2.46,"preClose":2.51,"latestTime":"19:50 EDT","volume":12471,"amount":31100.910600599997,"timestamp":1790898633552,"change":-0.05,"changeRate":-0.01992,"amplitude":0.055777},"volumeRatio":0.052815},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","floatShares":887600,"roa":"-57.13%","roe":"-459.52%","lyrEps":-192.076175,"volumeRatio":0.052815,"shares":887600,"dividePrice":0,"high":2.75,"amplitude":0.096429,"preClose":2.8,"low":2.48,"week52Low":2.05,"pbRate":"0.52","psRate":"-25.91","week52High":78.75,"institutionHeld":0,"latestPrice":2.51,"committee":-0.636364,"eps":-210.1984,"divideRate":0,"volume":680173,"delay":0,"ttmEps":-210.1984,"open":2.55,"prevYearClose":36.25,"prevWeekClose":3.03,"prevMonthClose":2.8,"prevQuarterClose":2.8,"fiveDayClose":3.48,"twentyDayClose":3.12,"sixtyDayClose":12.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-31","symbol":"VBIO","defaultRemindTime":1788183000000,"type":"split","dateTimestamp":1788148800000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VBIO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VBIO","date":"2026-09-30","current":-0.012465,"percent":0.413462,"low":-0.392475,"twenty":-0.187778,"median":-0.129233,"eighty":-0.077567,"high":-0.027033,"avg":-0.147,"sd":0.081638,"marketCap":2511876},"quantilePoints":[{"date":"2026-04-30","current":-0.311197,"twenty":-0.324163,"median":-0.319301,"eighty":-0.314439,"marketCap":2762808},{"date":"2026-05-08","current":-0.33713,"twenty":-0.336482,"median":-0.327405,"eighty":-0.314439,"marketCap":2993043},{"date":"2026-05-15","current":-0.329149,"twenty":-0.341701,"median":-0.33551,"eighty":-0.327405,"marketCap":2922183},{"date":"2026-05-22","current":-0.203146,"twenty":-0.339301,"median":-0.327405,"eighty":-0.203206,"marketCap":2758322},{"date":"2026-05-29","current":-0.18116,"twenty":-0.338751,"median":-0.311197,"eighty":-0.201597,"marketCap":2459794},{"date":"2026-06-05","current":-0.173392,"twenty":-0.33713,"median":-0.203331,"eighty":-0.18116,"marketCap":2354321},{"date":"2026-06-12","current":-0.138668,"twenty":-0.333889,"median":-0.20236,"eighty":-0.175704,"marketCap":1882829},{"date":"2026-06-18","current":-0.131547,"twenty":-0.330097,"median":-0.198754,"eighty":-0.158647,"marketCap":1786145},{"date":"2026-06-26","current":-0.136114,"twenty":-0.327754,"median":-0.18598,"eighty":-0.135201,"marketCap":1848155},{"date":"2026-07-02","current":-0.122229,"twenty":-0.327405,"median":-0.179125,"eighty":-0.130362,"marketCap":1659627},{"date":"2026-07-10","current":-0.117868,"twenty":-0.31768,"median":-0.175704,"eighty":-0.126637,"marketCap":1600412},{"date":"2026-07-17","current":-0.115133,"twenty":-0.303417,"median":-0.165705,"eighty":-0.121795,"marketCap":1563282},{"date":"2026-07-24","current":-0.06742,"twenty":-0.241361,"median":-0.149117,"eighty":-0.119839,"marketCap":915435},{"date":"2026-07-31","current":-0.065535,"twenty":-0.203355,"median":-0.136114,"eighty":-0.117713,"marketCap":889829},{"date":"2026-08-07","current":-0.064804,"twenty":-0.203188,"median":-0.130843,"eighty":-0.108033,"marketCap":879906},{"date":"2026-08-14","current":-0.040264,"twenty":-0.202832,"median":-0.129351,"eighty":-0.073786,"marketCap":546700},{"date":"2026-08-21","current":-0.027033,"twenty":-0.202055,"median":-0.126472,"eighty":-0.068316,"marketCap":506868},{"date":"2026-08-28","current":-0.145091,"twenty":-0.20046,"median":-0.129351,"eighty":-0.070603,"marketCap":2720462},{"date":"2026-09-04","current":-0.132547,"twenty":-0.198079,"median":-0.130843,"eighty":-0.073078,"marketCap":2485249},{"date":"2026-09-11","current":-0.104144,"twenty":-0.196943,"median":-0.130244,"eighty":-0.073125,"marketCap":1952695},{"date":"2026-09-18","current":-0.105564,"twenty":-0.194796,"median":-0.129235,"eighty":-0.07355,"marketCap":1979323},{"date":"2026-09-25","current":-0.164736,"twenty":-0.188071,"median":-0.128265,"eighty":-0.075261,"marketCap":3088809},{"date":"2026-09-30","current":-0.133967,"twenty":-0.187778,"median":-0.129233,"eighty":-0.077567,"marketCap":2511876}],"updateTime":1790869035155},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671019302","title":"Valion Bio, Shear Kershman formulate oral mucosal entolimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2671019302","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671019302?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:55","pubTimestamp":1790769334,"startTime":"0","endTime":"0","summary":"Valion Bio (VBIO) and Shear Kershman Laboratories announced the completion of formulation work under the companies’ ongoing program to develop a no...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valion-bio-shear-kershman-formulate-oral-mucosal-entolimod-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valion-bio-shear-kershman-formulate-oral-mucosal-entolimod-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671209410","title":"Valion Bio, Shear Kershman Complete Oral Mucosal Entolimod Formulation Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2671209410","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671209410?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:45","pubTimestamp":1790768738,"startTime":"0","endTime":"0","summary":"Valion Bio, Shear Kershman complete oral mucosal Entolimod formulation milestoneValion Bio reported successful formulation of an oral mucosal Entolimod using Shear Kershman’s BioViscid drug-delivery p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL6YN4jt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669485224","title":"Valion Bio appoints Dean Zikria as interim CEO, Thomas Jensen as chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2669485224","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669485224?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:26","pubTimestamp":1790166377,"startTime":"0","endTime":"0","summary":"Valion Bio (VBIO) announced decisive changes to its executive leadership team and Board of Directors. These leadership transitions are intended to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valion-bio-appoints-dean-zikria-as-interim-ceo-thomas-jensen-as-chair-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valion-bio-appoints-dean-zikria-as-interim-ceo-thomas-jensen-as-chair-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669483405","title":"Valion Bio - Appoints Dean Zikria as Interim CEO Effective September 22, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669483405","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669483405?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:05","pubTimestamp":1790165112,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4139","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669483180","title":"Valion Bio Names Dean Zikria Interim CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669483180","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669483180?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:00","pubTimestamp":1790164859,"startTime":"0","endTime":"0","summary":"Valion Bio names Dean Zikria interim CEOValion Bio named board member Dean Zikria interim CEO to steer strategy, including Entolimod development and partnership efforts.Zikria previously held strategy","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDLYPfmS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669424931","title":"Valion Bio regains compliance with Nasdaq minimum bid price listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2669424931","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669424931?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:55","pubTimestamp":1790081710,"startTime":"0","endTime":"0","summary":"Valion Bio (VBIO) has received formal written notification from The Nasdaq Stock Market confirming that the Company has regained compliance with th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valion-bio-regains-compliance-with-nasdaq-minimum-bid-price-listing-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valion-bio-regains-compliance-with-nasdaq-minimum-bid-price-listing-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4139","BK4082","VBIO","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669013141","title":"Valion Bio Regains NASDAQ Compliance with $1 Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2669013141","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669013141?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:11","pubTimestamp":1790079084,"startTime":"0","endTime":"0","summary":"Valion Bio regains Nasdaq compliance with $1 minimum bid price ruleValion Bio regained compliance with Nasdaq’s $1 minimum bid price rule under Listing Rule 5550(a)(2).Nasdaq notified the company that","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL6r0dnL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992606","title":"Valion Bio Files Initial Beneficial Ownership Statement for Director Thomas Jensen","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992606","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992606?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:31","pubTimestamp":1789677107,"startTime":"0","endTime":"0","summary":"Valion Bio files initial beneficial ownership statement for director Thomas JensenValion Bio director Thomas Jensen filed an initial SEC Form 3 on Aug. 27, 2026.Disclaimer:This news brief was created ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDLNP1K2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885672","title":"Valion Bio Inc: Lisa Wolf Appointed as President & Chief Operating Officer; to Continue to Serve as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885672","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885672?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:08","pubTimestamp":1788264539,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664300038","title":"Valion Bio Names CFO Lisa Wolf President, COO After CEO Handley Exits","url":"https://stock-news.laohu8.com/highlight/detail?id=2664300038","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664300038?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:09","pubTimestamp":1788257356,"startTime":"0","endTime":"0","summary":"Valion Bio names CFO Lisa Wolf president, COO after CEO Handley exitsValion Bio appointed CFO Lisa Wolf as president and COO, taking executive leadership following former CEO Michael K. Handley’s depa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLbpTSS5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663871019","title":"Valion Bio Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2663871019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663871019?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:50","pubTimestamp":1787961014,"startTime":"0","endTime":"0","summary":"19:50 EDT Valion Bio (VBIO) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valion-bio-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valion-bio-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707915","title":"Valion Bio - 1-for-25 Reverse Stock Split, Become Effective on August 31 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707915","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662707915?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:33","pubTimestamp":1787833989,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707666","title":"Valion Bio Announces 1-for-25 Reverse Stock Split Effective Aug. 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707666","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662707666?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:30","pubTimestamp":1787833845,"startTime":"0","endTime":"0","summary":"Valion Bio announces 1-for-25 reverse stock split effective Aug. 31Valion Bio set a 1-for-25 reverse stock split, effective Aug. 31 at 12:01 a.m. ET.Shares expected to trade split-adjusted at the open","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL9z6cwd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232321","title":"Valion Bio Amends 8-K to Report Final Vote Tally on Reverse Stock Split Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232321","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232321?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:16","pubTimestamp":1787256978,"startTime":"0","endTime":"0","summary":"Valion Bio amends 8-K to report final vote tally on reverse stock split approvalValion Bio filed an amended 8-K to replace preliminary vote tallies with final results from its Aug. 14, 2026 special me","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL6tdpH8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660481304","title":"Valion Bio Agrees to Sell 1,500 Series B Preferred Shares to 3i for $1.5 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660481304","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660481304?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:26","pubTimestamp":1786962407,"startTime":"0","endTime":"0","summary":"Valion Bio agrees to sell 1,500 Series B preferred shares to 3i for $1.5 million in private placementValion Bio entered a $1.5 million private placement with 3i, LP, issuing 1,500 Series B Non-Voting ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2xxr71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489791","title":"Valion Bio - Michael K. Handley Terminated as Chief Executive Officer, Effective August 16 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489791?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:12","pubTimestamp":1786961545,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659541124","title":"Valion Bio Q2 Net Loss Widens to $7.1 Million; Operating Loss Deepens to $6.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659541124","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659541124?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:34","pubTimestamp":1786743242,"startTime":"0","endTime":"0","summary":"Valion Bio Q2 net loss widens to $7.1 million; operating loss deepens to $6.4 millionValion Bio posted a GAAP net loss of $7.1 million for Q2 2026, widening from $1.93 million a year earlier.GAAP oper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL5gktBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659688351","title":"Ukraine Health Ministry Starts Technical Assessment of Valion Bio’s Entolimod Dossier","url":"https://stock-news.laohu8.com/highlight/detail?id=2659688351","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659688351?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:00","pubTimestamp":1786629618,"startTime":"0","endTime":"0","summary":"Ukraine health ministry starts technical assessment of Valion Bio’s Entolimod dossierUkraine’s Ministry of Health accepted Valion Bio’s Entolimod dossier for formal review on July 22, 2026.Technical a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1S7tbv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159403","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159403","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159403?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620654,"startTime":"0","endTime":"0","summary":"Leslie's (LESL) shares were down more than 42% premarket Thursday following the company's fiscal Q3 financial results.Valion Bio (VBIO) stock was 30% lower, continuing from a 27% fall in the prior ses","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","OTLK","FGL","LESL","NCPL","BK4135","BK4129","VBIO","BK4200","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658890662","title":"Valion Bio Says U.S.-Funded Entolimod Safety Study for Radiation-Induced GI Injury Starts This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2658890662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658890662?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:23","pubTimestamp":1786548204,"startTime":"0","endTime":"0","summary":"Valion Bio says U.S.-funded Entolimod safety study for radiation-induced GI injury starts this weekValion Bio disclosed a U.S. government-funded AFRRI/NIAID program testing Entolimod for lethal radiat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL77sszd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}]}}